BDBM324211 US10189819, Example 48::US10189819, Example 54

SMILES COc1cc2nc([nH]c2cc1Cl)C(CNC(=O)c1c(Cl)cc(cc1Cl)-n1cnc(C)n1)c1cccc(F)c1

InChI Key

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 324211   

TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM324211(US10189819, Example 48 | US10189819, Example 54)
Affinity DataIC50:  2.86nMAssay Description:Formation of a clot to stem bleeding at a site of blood vessel injury involves the coordinated activity of a group of plasma proteins that initiate a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM324211(US10189819, Example 48 | US10189819, Example 54)
Affinity DataIC50:  2.86nMAssay Description:Formation of a clot to stem bleeding at a site of blood vessel injury involves the coordinated activity of a group of plasma proteins that initiate a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent